{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:54:49Z","timestamp":1768290889426,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,3,17]]},"DOI":"10.1038\/onc.2010.510","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T11:19:03Z","timestamp":1289215143000},"page":"1290-1301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22"],"prefix":"10.1038","volume":"30","author":[{"given":"J B","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H N","family":"Appaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bhat-Nakshatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Badve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Steeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Nakshatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"BFonc2010510_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.bjc.6601541","volume":"90","author":"P Bhat-Nakshatri","year":"2004","unstructured":"Bhat-Nakshatri P, Campbell RA, Patel NM, Newton TR, King AJ, Marshall MS et al. (2004). Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function. Br J Cancer 90: 853\u2013859.","journal-title":"Br J Cancer"},{"key":"BFonc2010510_CR2","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1093\/nar\/gkp500","volume":"37","author":"P Bhat-Nakshatri","year":"2009","unstructured":"Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS et al. (2009). Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850\u20134861.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2010510_CR3","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","volume":"8","author":"C Blenkiron","year":"2007","unstructured":"Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ et al. (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype. Genome Biol 8: R214.","journal-title":"Genome Biol"},{"key":"BFonc2010510_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1078-0432.CCR-09-1218","volume":"16","author":"MR Campbell","year":"2010","unstructured":"Campbell MR, Amin D, Moasser MM . (2010). HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy. Clin Cancer Res 16: 1373\u20131383.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010510_CR5","doi-asserted-by":"publisher","first-page":"15732","DOI":"10.1073\/pnas.0906947106","volume":"106","author":"L Castellano","year":"2009","unstructured":"Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P et al. (2009). The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106: 15732\u201315737.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010510_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFonc2010510_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.onc.1209808","volume":"26","author":"HL Chua","year":"2007","unstructured":"Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H . (2007). NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711\u2013724.","journal-title":"Oncogene"},{"key":"BFonc2010510_CR8","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","volume":"13","author":"C Desmedt","year":"2007","unstructured":"Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B et al. (2007). Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207\u20133214.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010510_CR9","doi-asserted-by":"publisher","first-page":"e7181","DOI":"10.1371\/journal.pone.0007181","volume":"4","author":"DM Dykxhoorn","year":"2009","unstructured":"Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, Petrocca F et al. (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4: e7181.","journal-title":"PLoS One"},{"key":"BFonc2010510_CR10","doi-asserted-by":"publisher","first-page":"15215","DOI":"10.1074\/jbc.M511408200","volume":"281","author":"GP Elvidge","year":"2006","unstructured":"Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM . (2006). Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215\u201315226.","journal-title":"J Biol Chem"},{"key":"BFonc2010510_CR11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrc1075","volume":"3","author":"P Friedl","year":"2003","unstructured":"Friedl P, Wolf K . (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362\u2013374.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2010510_CR12","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1101\/gad.1820209","volume":"23","author":"DL Gibbons","year":"2009","unstructured":"Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ et al. (2009). Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 23: 2140\u20132151.","journal-title":"Genes Dev"},{"key":"BFonc2010510_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/leu.2009.202","volume":"24","author":"S Goyama","year":"2010","unstructured":"Goyama S, Nitta E, Yoshino T, Kako S, Watanabe-Okochi N, Shimabe M et al. (2010). EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia 24: 81\u201388.","journal-title":"Leukemia"},{"key":"BFonc2010510_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/jnci\/djn216","volume":"100","author":"B Gril","year":"2008","unstructured":"Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L et al. (2008). Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100: 1092\u20131103.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2010510_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/sqb.2005.70.018","volume":"70","author":"GP Gupta","year":"2005","unstructured":"Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C et al. (2005). Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 70: 149\u2013158.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"BFonc2010510_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. (2010). An online survival analysis tool to rapidly assess the effect of 22\u2009277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat 123: 725\u2013731.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2010510_CR17","doi-asserted-by":"publisher","first-page":"21631","DOI":"10.1074\/jbc.M300609200","volume":"278","author":"G Helbig","year":"2003","unstructured":"Helbig G, Christopherson II KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631\u201321638.","journal-title":"J Biol Chem"},{"key":"BFonc2010510_CR18","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1523\/JNEUROSCI.1384-07.2007","volume":"27","author":"M Hoser","year":"2007","unstructured":"Hoser M, Baader SL, Bosl MR, Ihmer A, Wegner M, Sock E . (2007). Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia. J Neurosci 27: 5495\u20135505.","journal-title":"J Neurosci"},{"key":"BFonc2010510_CR19","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1158\/0008-5472.CAN-09-2111","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst DR, Edmonds MD, Welch DR . (2009). Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495\u20137498.","journal-title":"Cancer Res"},{"key":"BFonc2010510_CR20","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1101\/gad.1616307","volume":"21","author":"I Ibarra","year":"2007","unstructured":"Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon GJ . (2007). A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 21: 3238\u20133243.","journal-title":"Genes Dev"},{"key":"BFonc2010510_CR21","doi-asserted-by":"publisher","first-page":"e3740","DOI":"10.1371\/journal.pone.0003740","volume":"3","author":"D Iliopoulos","year":"2008","unstructured":"Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A . (2008). Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 3: e3740.","journal-title":"PLoS One"},{"key":"BFonc2010510_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S . (2010). MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252\u2013263.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2010510_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537\u2013549.","journal-title":"Cancer Cell"},{"key":"BFonc2010510_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1158\/1055-9965.EPI-10-0071","volume":"19","author":"J Koshiol","year":"2010","unstructured":"Koshiol J, Wang E, Zhao Y, Marincola F, Landi MT . (2010). Strengths and limitations of laboratory procedures for microRNA detection. Cancer Epidemiol Biomarkers Prev 19: 907\u2013911.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc2010510_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jcp.21953","volume":"222","author":"K Kumano","year":"2010","unstructured":"Kumano K, Kurokawa M . (2010). The role of Runx1\/AML1 and Evi-1 in the regulation of hematopoietic stem cells. J Cell Physiol 222: 282\u2013285.","journal-title":"J Cell Physiol"},{"key":"BFonc2010510_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15\u201320.","journal-title":"Cell"},{"key":"BFonc2010510_CR27","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1038\/sj.onc.1209403","volume":"25","author":"Y Liu","year":"2006","unstructured":"Liu Y, Chen L, Ko TC, Fields AP, Thompson EA . (2006). Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K\/AKT. Oncogene 25: 3565\u20133575.","journal-title":"Oncogene"},{"key":"BFonc2010510_CR28","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1158\/0008-5472.CAN-09-2206","volume":"69","author":"G Maillot","year":"2009","unstructured":"Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Benes V et al. (2009). Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 69: 8332\u20138340.","journal-title":"Cancer Res"},{"key":"BFonc2010510_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-5-24","volume":"5","author":"MD Mattie","year":"2006","unstructured":"Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK et al. (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24.","journal-title":"Mol Cancer"},{"key":"BFonc2010510_CR30","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550\u201313555.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010510_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/me.2009-0295","volume":"24","author":"AK Nagaraja","year":"2010","unstructured":"Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG et al. (2010). A link between mir-100 and FRAP1\/mTOR in clear cell ovarian cancer. Mol Endocrinol 24: 447\u2013463.","journal-title":"Mol Endocrinol"},{"key":"BFonc2010510_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrc2619","volume":"9","author":"MS Nicoloso","year":"2009","unstructured":"Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA . (2009). MicroRNAs\u2014the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293\u2013302.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2010510_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/bcr2484","volume":"12","author":"E O'Day","year":"2010","unstructured":"O'Day E, Lal A . (2010). MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 12: 201.","journal-title":"Breast Cancer Res"},{"key":"BFonc2010510_CR34","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1128\/MCB.01875-08","volume":"29","author":"DP Pandey","year":"2009","unstructured":"Pandey DP, Picard D . (2009). miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29: 3783\u20133790.","journal-title":"Mol Cell Biol"},{"key":"BFonc2010510_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR . (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49\u201354.","journal-title":"Nat Genet"},{"key":"BFonc2010510_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2006.01.013","volume":"9","author":"AL Richardson","year":"2006","unstructured":"Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A et al. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121\u2013132.","journal-title":"Cancer Cell"},{"key":"BFonc2010510_CR37","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1158\/0008-5472.CAN-07-5206","volume":"68","author":"M Schmidt","year":"2008","unstructured":"Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H et al. (2008). The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68: 5405\u20135413.","journal-title":"Cancer Res"},{"key":"BFonc2010510_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature05474","volume":"445","author":"NV Sergina","year":"2007","unstructured":"Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM et al. (2007). Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 445: 437\u2013441.","journal-title":"Nature"},{"key":"BFonc2010510_CR39","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1038\/onc.2009.288","volume":"28","author":"M Shimabe","year":"2009","unstructured":"Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, Imai Y et al. (2009). Pbx1 is a downstream target of Evi-1 in hematopoietic stem\/progenitors and leukemic cells. Oncogene 28: 4364\u20134374.","journal-title":"Oncogene"},{"key":"BFonc2010510_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J et al. (2006). Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262\u2013272.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2010510_CR41","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS . (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895\u2013904.","journal-title":"Nat Med"},{"key":"BFonc2010510_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1158\/1535-7163.MCT-07-2272","volume":"7","author":"M Sun","year":"2008","unstructured":"Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R . (2008). Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464\u2013473.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2010510_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147\u2013152.","journal-title":"Nature"},{"key":"BFonc2010510_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","volume":"137","author":"S Valastyan","year":"2009","unstructured":"Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032\u20131046.","journal-title":"Cell"},{"key":"BFonc2010510_CR45","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1126\/science.1165395","volume":"322","author":"S Varambally","year":"2008","unstructured":"Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B et al. (2008). Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695\u20131699.","journal-title":"Science"},{"key":"BFonc2010510_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)70933-8","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671\u2013679.","journal-title":"Lancet"},{"key":"BFonc2010510_CR47","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.gene.2007.04.012","volume":"396","author":"R Wieser","year":"2007","unstructured":"Wieser R . (2007). The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene 396: 346\u2013357.","journal-title":"Gene"},{"key":"BFonc2010510_CR48","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917\u20131920.","journal-title":"Science"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010510","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:22:09Z","timestamp":1647883329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3,17]]}},"alternative-id":["BFonc2010510"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.510","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,8]]},"assertion":[{"value":"6 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}